HYPF yields 2000000.00% · PFE yields 6.20%● Live data
📍 HYPF pulled ahead of the other in Year 1
Combined, HYPF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of HYPF + PFE for your $10,000?
Hypower Fuel, Inc., a development stage company, focuses on developing and supplying alternative fuel sources in North America. It specializes in hydrogen production and hydrogen related products. The company developed proprietary technologies to reduce dependence on fossil fuels, as well as to eliminate harmful toxic emissions that threaten environment. Its products include the Hydro Power Pak (HPP), a retrofit hydrogen insertion device for use on tractor trailer rigs, as well as on stationary diesel engines to enhance fuel economy, reduce harmful emissions, and enhance engine performance and horsepower; and Hydrogen Reactor under development to produce hydrogen on board to power a gasoline engine. Hypower Fuel's product portfolio also consists of an interface control module (ICM) to work in either a stand-alone application with an engine's fuel delivery system or in conjunction with the HPP under programming and testing stage for applications in the trucking industry. ICM's capabilities include enhanced horsepower rating, monitoring engine operations, data acquisition, and global positioning systems. The company also developed a manufacturing process to produce an organic diesel fuel lubrication additive, Bio-Lube, for enhancing lubricity to protect diesel fuel injectors and pumps; and replacing hydrocarbon two stroke oils to reduce harmful toxic emissions and provide enhanced lubrication. Hypower Fuel, Inc. was incorporated in 1987 and is headquartered in High River, Canada.
Full HYPF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.